Prominent hematogone hyperplasia in BCR-ABL1-positive chronic myelogenous leukemia: mimicking recurrent B-lymphoid blast crisis

Leuk Lymphoma. 2014 Aug;55(8):1952-4. doi: 10.3109/10428194.2013.869330. Epub 2014 Feb 6.

Authors

Pedro Horna¹, Panagiotis Pantazopoulos, Jeffrey E Lancet, Lynn C Moscinski, Ling Zhang

Affiliation

¹ Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center , Tampa, FL , USA.

PMID: 24304373
DOI: 10.3109/10428194.2013.869330

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Blast Crisis / pathology*
Bone Marrow / pathology
Fusion Proteins, bcr-abl / genetics
Humans
Hyperplasia
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Precursor Cells, B-Lymphoid / pathology*

Substances

Fusion Proteins, bcr-abl